Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects

Diabetes mellitus, the most prevalent endocrine disorder, not only impacts the retina but also significantly involves the ocular surface. Diabetes contributes to the development of dry eye disease and induces morphological and functional corneal alterations, particularly affecting nerves and epithel...

Full description

Bibliographic Details
Published in:Antioxidants
Main Authors: Francesco Buonfiglio, Joanna Wasielica-Poslednik, Norbert Pfeiffer, Adrian Gericke
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Subjects:
Online Access:https://www.mdpi.com/2076-3921/13/1/120
_version_ 1850287083565875200
author Francesco Buonfiglio
Joanna Wasielica-Poslednik
Norbert Pfeiffer
Adrian Gericke
author_facet Francesco Buonfiglio
Joanna Wasielica-Poslednik
Norbert Pfeiffer
Adrian Gericke
author_sort Francesco Buonfiglio
collection DOAJ
container_title Antioxidants
description Diabetes mellitus, the most prevalent endocrine disorder, not only impacts the retina but also significantly involves the ocular surface. Diabetes contributes to the development of dry eye disease and induces morphological and functional corneal alterations, particularly affecting nerves and epithelial cells. These changes manifest as epithelial defects, reduced sensitivity, and delayed wound healing, collectively encapsulated in the context of diabetic keratopathy. In advanced stages of this condition, the progression to corneal ulcers and scarring further unfolds, eventually leading to corneal opacities. This critical complication hampers vision and carries the potential for irreversible visual loss. The primary objective of this review article is to offer a comprehensive overview of the pathomechanisms underlying diabetic keratopathy. Emphasis is placed on exploring the redox molecular pathways responsible for the aberrant structural changes observed in the cornea and tear film during diabetes. Additionally, we provide insights into the latest experimental findings concerning potential treatments targeting oxidative stress. This endeavor aims to enhance our understanding of the intricate interplay between diabetes and ocular complications, offering valuable perspectives for future therapeutic interventions.
format Article
id doaj-art-e9c3cd065e664832a66bb50bd98e6bf7
institution Directory of Open Access Journals
issn 2076-3921
language English
publishDate 2024-01-01
publisher MDPI AG
record_format Article
spelling doaj-art-e9c3cd065e664832a66bb50bd98e6bf72025-08-19T23:37:03ZengMDPI AGAntioxidants2076-39212024-01-0113112010.3390/antiox13010120Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic ProspectsFrancesco Buonfiglio0Joanna Wasielica-Poslednik1Norbert Pfeiffer2Adrian Gericke3Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyDepartment of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyDiabetes mellitus, the most prevalent endocrine disorder, not only impacts the retina but also significantly involves the ocular surface. Diabetes contributes to the development of dry eye disease and induces morphological and functional corneal alterations, particularly affecting nerves and epithelial cells. These changes manifest as epithelial defects, reduced sensitivity, and delayed wound healing, collectively encapsulated in the context of diabetic keratopathy. In advanced stages of this condition, the progression to corneal ulcers and scarring further unfolds, eventually leading to corneal opacities. This critical complication hampers vision and carries the potential for irreversible visual loss. The primary objective of this review article is to offer a comprehensive overview of the pathomechanisms underlying diabetic keratopathy. Emphasis is placed on exploring the redox molecular pathways responsible for the aberrant structural changes observed in the cornea and tear film during diabetes. Additionally, we provide insights into the latest experimental findings concerning potential treatments targeting oxidative stress. This endeavor aims to enhance our understanding of the intricate interplay between diabetes and ocular complications, offering valuable perspectives for future therapeutic interventions.https://www.mdpi.com/2076-3921/13/1/120diabetic complicationcorneakeratopathyredoxpathwaysmolecular
spellingShingle Francesco Buonfiglio
Joanna Wasielica-Poslednik
Norbert Pfeiffer
Adrian Gericke
Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
diabetic complication
cornea
keratopathy
redox
pathways
molecular
title Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
title_full Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
title_fullStr Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
title_full_unstemmed Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
title_short Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects
title_sort diabetic keratopathy redox signaling pathways and therapeutic prospects
topic diabetic complication
cornea
keratopathy
redox
pathways
molecular
url https://www.mdpi.com/2076-3921/13/1/120
work_keys_str_mv AT francescobuonfiglio diabetickeratopathyredoxsignalingpathwaysandtherapeuticprospects
AT joannawasielicaposlednik diabetickeratopathyredoxsignalingpathwaysandtherapeuticprospects
AT norbertpfeiffer diabetickeratopathyredoxsignalingpathwaysandtherapeuticprospects
AT adriangericke diabetickeratopathyredoxsignalingpathwaysandtherapeuticprospects